Comedian Amy Schumer revealed she has exogenous Cushing’s syndrome brought on by steroid injections. (CNN)
The one-anastomosis gastric bypass (OAGB) procedure was not inferior to Roux-en-Y gastric bypass procedure when it came to 5-year weight-loss and metabolic outcomes, but OAGB led to high rates of gastroesophageal reflux disease. (Lancet Diabetes & Endocrinology)
Over 1 billion people globally — or one in eight — are living with obesity, with the rate among children and teens quadrupling from 1990 to 2022. (The Lancet)
Novo Nordisk said its 1-mg dose of semaglutide (Ozempic) delayed progression of chronic kidney disease for patients with type 2 diabetes in the placebo-controlled FLOW trial, lowering the risk of kidney disease-related events — including cardiovascular and kidney death — by 24%.
A single-center randomized trial suggested that high-dose ergocalciferol — also known as vitamin D2 — may help preserve β-cell function in kids with new-onset type 1 diabetes and prolong the partial remission phase. (JAMA Network Open)
The Endocrine Society announced plans to review its clinical guidelines for gender-affirming care. (CNN)
And the society also called on Congress to support federal protection of in vitro fertilization (IVF) access.
Plant-based diets in postmenopausal women were not associated with increased hip fracture risk, new findings from the U.S. Nurses’ Health Study revealed. (JAMA Network Open)
The GLP-1 receptor agonist liraglutide (Victoza, Saxenda) was effective for weight loss in people with stable bipolar disorder and overweight or obesity. (Journal of Clinical Psychopharmacology)
Kids born to mothers with obesity who continued to have obesity post-pregnancy were 146% more likely to develop obesity themselves. (Epic Research)
In a post hoc analysis of the Look AHEAD trial, maintaining weight loss and higher physical activity volume was linked with a 61% lower risk of cardiovascular events in people with type 2 diabetes and obesity. (JAMA Network Open)
-
Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.
Please enable JavaScript to view the